Determinants of renal functional outcome in lupus nephritis: A single centre retrospective study

QJM: An International Journal of Medicine

Volumn 101, Issue 4, 2008, Pages 313-316

  Chrysochou, Constantina ^a   Randhawa, Harpreet ^a   Reeve, Roy ^a   Waldek, Stephen ^a   Wood, Grahame N ^a   O'Donoghue, Donal J ^a   Kalra, Philip A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MONOTHERAPY; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT;

EID: 41149150828     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn008     Document Type: Article

References (13)

1. Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: Diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 2006; 33:1563-9.
2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
3. von EE, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Epidemiology 2007; 18:800-4.
4. Austin HA III, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995; 10 1620-8.
5. Specker C, Becker A, Lakomek HJ, Bach D, Grabensee B. Systemic lupus erythematosus in men - a different prognosis? Z Rheumatol 1994; 53:339-45.
6. Castellino G, Govoni M, Prandini N, Limpido G, Bernardi S, Campione D, et al. Thrombocytosis in systemic lupus erythematosus: A possible clue to autosplenectomy? J Rheumatol 2007; 34:1497-501.
7. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10 413-24.
8. Derksen RH, Hene RJ, Kater L. The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center. Lupus 1992; 1:97-103.
9. Howie AJ, Turhan N, Adu D. Powerful morphometric indicator of prognosis in lupus nephritis. Q J Med 2003; 96:411-20.
10. Martens HA, Bijl M, Kallenberg CG. Prognostic value of renal hemodynamic characteristics in patients with proliferative lupus nephritis. Kidney Blood Press Res 2007; 30:175-81.
11. Martins L, Rocha G, Rodrigues A, Santos J, Vasconcelos C, Correia J, et al. Lupus nephritis: A retrospective review of 78 cases from a single center. Clin Nephrol 2002; 57:114-9.
12. Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, et al. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2007; 22:1933-42.
13. Mok CC. Prognostic factors in lupus nephritis. Lupus 2005; 14 39-44.